Therefore, poor prognosis patients with low ALOX12B expression had high infiltration of CAFs surrounding tumor cells, and rapamycin or everolimus may provide survival benefits by inhibiting mTOR signaling. The gene discussed is MTOR; the disease is neoplasm.